FOLH1 and prostate carcinoma: With the introduction of 68Ga-PMSA-HBED-CC PET imaging in patients suffering from prostate carcinoma, incidental uptake of 68Ga-PSMA-HBED-CC found in thyroid lesions has led a limited number of authors to explore in more detail the uptake of PSMA-targeting PET ligands by thyroid carcinoma neovasculature.